Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ofer Feder

Gastroenterology Mechanicsville, VA Medical Doctor

NPI 1801882501 CMS profile 172489

8266 Atlee Rd, Suite 133, Mechanicsville, VA 23116

Open in the dashboard

General payments

$4,811

251 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ofer Feder of Mechanicsville, VA is reported in the CMS Open Payments database as having received $4,811 across 251 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 66th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $722 30
2024 General $611 22
2023 General $1,017 50
2022 General $851 51
2021 General $863 49
2020 General $217 10
2019 General $530 39

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ofer Feder
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Ofer Feder were reported at $722. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Ofer Feder Gastroenterology median Middle half National median
2019 $530 $417 $126–$1,100 $163
2020 $217 $224 $74–$624 $114
2021 $863 $352 $106–$1,054 $132
2022 $851 $448 $129–$1,270 $149
2023 $1,017 $533 $150–$1,390 $160
2024 $611 $605 $160–$1,606 $164
2025 $722 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $1,730 91 payments
  2. Pfizer Inc. $553 31 payments
  3. Celgene Corporation $437 29 payments
  4. Janssen Biotech, Inc. $233 15 payments
  5. Salix Pharmaceuticals, a division of Bausch Health US, LLC $157 8 payments
  6. Takeda Pharmaceuticals U.S.A., Inc. $154 14 payments
  7. CONMED Corporation $143 1 payment
  8. Alnylam Pharmaceuticals Inc. $141 5 payments
  9. Nestle HealthCare Nutrition Inc. $114 6 payments
  10. Gilead Sciences, Inc. $100 6 payments
  11. Other $1,050 45 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,795 250 payments
  2. Consulting Fee $16 1 payment
Products named General payments · program years 2019–2025
  1. HUMIRA $572 32 payments
  2. ZEPOSIA $419 28 payments
  3. RINVOQ $396 18 payments
  4. XELJANZ $356 20 payments
  5. LINZESS $319 18 payments
  6. SKYRIZI $278 15 payments
  7. VELSIPITY $226 12 payments
  8. CREON $212 12 payments
  9. STELARA $172 12 payments
  10. XIFAXAN $157 8 payments
  11. Other $2,113 88 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 18 drugs

Part D claims

1,642

Median for Gastroenterology: 569

Drug cost

$273,626

Median for Gastroenterology: $104,976

Branded share of claims

23.4%

Median for Gastroenterology: 31.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Humira(Cf) Pen Adalimumab Brand 21 $162,919
Creon Lipase/Protease/Amylase Brand 13 $53,583
Mesalamine Er Mesalamine Brand 22 $14,362
Mesalamine Generic 48 $8,822
Lubiprostone Generic 14 $5,237
Omeprazole Generic 555 $5,123
Famotidine Generic 287 $4,351
Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates Brand 62 $4,020
Colestipol Hcl Generic 40 $2,790
Budesonide Dr Budesonide Brand 24 $2,655

The 10 drugs with the highest cost, of 18 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,294 Part D prescribers listed as Gastroenterology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$97,015

Medicare's payments for the services billed

Medicare patients

546

Average age 75

Services billed

896

317 women, 229 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 47%
Ischemic heart disease 33%
Diabetes 31%
Chronic kidney disease 28%
Depression 24%
Atrial fibrillation 23%
COPD 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 11 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VELSIPITY
  • PFIZER INC. $153
$153 — —
CREON
  • AbbVie, Inc. $46
$46 13 —
SANCUSO
  • Cumberland Pharmaceuticals, Inc. $25
$25 — —
LINZESS
  • AbbVie, Inc. $21
$21 — —
TREMFYA
  • Janssen Biotech, Inc. $21
$21 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 11 in the dashboard with a free account

Records

251 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record